Leukemia and/or myeloproliferative syndrome in neonates with Down syndrome.
Approximately 10% of newborn infants with Down Syndrome develop a form of megakaryoblastic leukemia which usually disappears spontaneously during the first months of life. The evidence that this "Transient Leukemia" is truly leukemia includes the following: it is clonal proliferation, it can be fatal and tissue infiltration of leukemic cells occurs. Also in approximately 25% of cases that recover, Acute Megakaryoblastic Leukemia will develop in the first four years of life, which, if not treated, is fatal. Evidence regarding the megakaryoblastic nature of the leukemic cells is presented as well as a description of the lethal forms of the disease. The study of Transient Leukemia is of considerable importance because it can provide insight into both the nature of leukemia and its relation to trisomy 21.
Zipursky
A
A
Department of Pediatrics, Hospital for Sick Children, University of Toronto, Ontario, Canada.
Brown
E
E
Christensen
H
H
Sutherland
R
R
Doyle
J
J
D001706:Biopsy; D001853:Bone Marrow / Q000473:pathology; D002455:Cell Division / Q000502:physiology; D003937:Diagnosis, Differential; D004314:Down Syndrome / Q000235:genetics*; D006801:Humans; D007231:Infant, Newborn; D007947:Leukemia, Megakaryoblastic, Acute / Q000175:diagnosis* / Q000235:genetics / Q000401:mortality; D009196:Myeloproliferative Disorders / Q000175:diagnosis* / Q000235:genetics / Q000401:mortality; D010976:Platelet Count